Physician profile
Michael N Bohan
NPI 1417920315
$920.83
in general payments reported to CMS, 2019-2025
14 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2020: $50.03 · 2021: $75.11 · 2022: $161 · 2023: $91.80 · 2024: $115 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $333.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $344.21 | 2019-2022 | |
| Medline Industries Lp | $136.79 | 2024-2025 | Medline Industries, INC. |
| Smith+Nephew, INC. | $107.22 | 2021-2025 | Pico |
| Peerless Surgical INC. | $74.76 | 2023 | |
| Boston Scientific Corporation | $46.40 | 2019-2020 | |
| Pacira Therapeutics, INC. | $40.41 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $38.80 | 2023-2025 | Iovera, Zilretta, Exparel |
| Convatec INC. | $30.58 | 2021-2024 | |
| Next Science LLC | $29.30 | 2020 | |
| Medical Device Business Services, INC. | $19.68 | 2021 | |
| Molnlycke Health Care US, LLC | $15.86 | 2025 | Avance, Mepilex Border Post-Op Ag |
| Kci USA, INC. | $14.08 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.03 | 2022 | |
| Conformis, INC. | $9.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bohan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.